跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BETASERC 24 TABLET 24 mg - HSA Drug Approval Details
Approvals
/
HSA
/
BETASERC 24 TABLET 24 mg
Approved
THERAPEUTIC
BETASERC 24 TABLET 24 mg
Mylan Laboratories SAS (FRANCE)
🇸🇬 Health Sciences Authority
Approval Date
Mar 24, 2003
Approval ID
83b0041e5e5f209a
Company
Mylan Laboratories SAS (FRANCE)
Type
Therapeutic
Approval Details
Approval Id
83b0041e5e5f209a
Drug Name
BETASERC 24 TABLET 24 mg
Product Name
BETASERC 24 TABLET 24 mg
Approval Number
SIN12235P
Approval Date
2003-03-24
Registrant
ABBOTT LABORATORIES (SINGAPORE ) PRIVATE LIMITED
Licence Holder
ABBOTT LABORATORIES (SINGAPORE) PRIVATE LIMITED
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
N07CA01
Atc Item Name
betahistine
Pharma Manufacturer Name
ABBOTT LABORATORIES (SINGAPORE ) PRIVATE LIMITED
Active Ingredients
BETAHISTINE 2HCl
24 mg
BETAHISTINE 2HCl
24 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Mar 24, 2003
Approval ID
83b0041e5e5f209a
Type
Therapeutic
Back to HSA Approvals